134 related articles for article (PubMed ID: 24443139)
41. Polyanhydride nanoparticles stabilize pancreatic cancer antigen MUC4β.
Liu L; Kshirsagar P; Christiansen J; Gautam SK; Aithal A; Gulati M; Kumar S; Solheim JC; Batra SK; Jain M; Wannemuehler MJ; Narasimhan B
J Biomed Mater Res A; 2021 Jun; 109(6):893-902. PubMed ID: 32776461
[TBL] [Abstract][Full Text] [Related]
42. Amphiphilic polyanhydride nanoparticles stabilize Bacillus anthracis protective antigen.
Petersen LK; Phanse Y; Ramer-Tait AE; Wannemuehler MJ; Narasimhan B
Mol Pharm; 2012 Apr; 9(4):874-82. PubMed ID: 22380593
[TBL] [Abstract][Full Text] [Related]
43. Combination Nanovaccine Demonstrates Synergistic Enhancement in Efficacy against Influenza.
Ross K; Adams J; Loyd H; Ahmed S; Sambol A; Broderick S; Rajan K; Kohut M; Bronich T; Wannemuehler MJ; Carpenter S; Mallapragada S; Narasimhan B
ACS Biomater Sci Eng; 2016 Mar; 2(3):368-374. PubMed ID: 33429541
[TBL] [Abstract][Full Text] [Related]
44. Amphiphilic polyanhydrides for protein stabilization and release.
Torres MP; Determan AS; Anderson GL; Mallapragada SK; Narasimhan B
Biomaterials; 2007 Jan; 28(1):108-16. PubMed ID: 16965812
[TBL] [Abstract][Full Text] [Related]
45. Preparation and degradation behavior of polyanhydrides nanoparticles.
Lee WC; Chu IM
J Biomed Mater Res B Appl Biomater; 2008 Jan; 84(1):138-46. PubMed ID: 17474078
[TBL] [Abstract][Full Text] [Related]
46. High-Throughput Synthesis and Screening of Rapidly Degrading Polyanhydride Nanoparticles.
Mullis AS; Jacobson SJ; Narasimhan B
ACS Comb Sci; 2020 Apr; 22(4):172-183. PubMed ID: 32125826
[TBL] [Abstract][Full Text] [Related]
47. Synthesis and Characterization of Rapidly Degrading Polyanhydrides as Vaccine Adjuvants.
Kelly SM; Mitra A; Mathur S; Narasimhan B
ACS Biomater Sci Eng; 2020 Jan; 6(1):265-276. PubMed ID: 33463223
[TBL] [Abstract][Full Text] [Related]
48. Mechanistic relationships between polymer microstructure and drug release kinetics in bioerodible polyanhydrides.
Shen E; Kipper MJ; Dziadul B; Lim MK; Narasimhan B
J Control Release; 2002 Jul; 82(1):115-25. PubMed ID: 12106982
[TBL] [Abstract][Full Text] [Related]
49. Harvesting murine alveolar macrophages and evaluating cellular activation induced by polyanhydride nanoparticles.
Chavez-Santoscoy AV; Huntimer LM; Ramer-Tait AE; Wannemuehler M; Narasimhan B
J Vis Exp; 2012 Jun; (64):e3883. PubMed ID: 22710245
[TBL] [Abstract][Full Text] [Related]
50. Alternating Poly(ester-anhydride) by Insertion Polycondensation.
Haim-Zada M; Basu A; Hagigit T; Schlinger R; Grishko M; Kraminsky A; Hanuka E; Domb AJ
Biomacromolecules; 2016 Jun; 17(6):2253-9. PubMed ID: 27198864
[TBL] [Abstract][Full Text] [Related]
51. Polyanhydride Nanovaccines Induce Germinal Center B Cell Formation and Sustained Serum Antibody Responses.
Vela Ramirez JE; Tygrett LT; Hao J; Habte HH; Cho MW; Greenspan NS; Waldschmidt TJ; Narasimhan B
J Biomed Nanotechnol; 2016 Jun; 12(6):1303-11. PubMed ID: 27319223
[TBL] [Abstract][Full Text] [Related]
52. Safety and biocompatibility of carbohydrate-functionalized polyanhydride nanoparticles.
Vela-Ramirez JE; Goodman JT; Boggiatto PM; Roychoudhury R; Pohl NL; Hostetter JM; Wannemuehler MJ; Narasimhan B
AAPS J; 2015 Jan; 17(1):256-67. PubMed ID: 25421457
[TBL] [Abstract][Full Text] [Related]
53. Functionalization promotes pathogen-mimicking characteristics of polyanhydride nanoparticle adjuvants.
Phanse Y; Carrillo-Conde BR; Ramer-Tait AE; Roychoudhury R; Broderick S; Pohl N; Rajan K; Narasimhan B; Wannemuehler MJ; Bellaire BH
J Biomed Mater Res A; 2017 Oct; 105(10):2762-2771. PubMed ID: 28556563
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of poly (1, 6-bis-(p-carboxyphenoxy) hexane-co-sebacic acid microspheres for controlled basal insulin delivery.
Manoharan C; Singh J
Pharm Res; 2013 Mar; 30(3):627-40. PubMed ID: 22975807
[TBL] [Abstract][Full Text] [Related]
55. pH-Responsive Microencapsulation Systems for the Oral Delivery of Polyanhydride Nanoparticles.
Sharpe LA; Vela Ramirez JE; Haddadin OM; Ross KA; Narasimhan B; Peppas NA
Biomacromolecules; 2018 Mar; 19(3):793-802. PubMed ID: 29443509
[TBL] [Abstract][Full Text] [Related]
56. Characterizing the antitumor response in mice treated with antigen-loaded polyanhydride microparticles.
Joshi VB; Geary SM; Carrillo-Conde BR; Narasimhan B; Salem AK
Acta Biomater; 2013 Mar; 9(3):5583-9. PubMed ID: 23153760
[TBL] [Abstract][Full Text] [Related]
57. Development and validation of a mass spectrometry based analytical method to quantify the ratios in hemagglutinin trimers in quadrivalent influenza nanoparticle vaccine - FluMos-v1.
Shajahan A; Cai CX; Wolff J; Yang RS; Ivleva VB; Gowetski DB; Gall JGD; Lei QP
Anal Methods; 2023 Feb; 15(7):896-900. PubMed ID: 36723411
[TBL] [Abstract][Full Text] [Related]
58. Poly(fumaric-co-sebacic anhydride). A degradation study as evaluated by FTIR, DSC, GPC and X-ray diffraction.
Santos CA; Freedman BD; Leach KJ; Press DL; Scarpulla M; Mathiowitz E
J Control Release; 1999 Jun; 60(1):11-22. PubMed ID: 10370167
[TBL] [Abstract][Full Text] [Related]
59. Using LC-MS to Identify Clipping in Self-Assembled Nanoparticles During Vaccine Development.
Schneck NA; Ivleva VB; Rosales-Zavala E; Wang X; Gollapudi D; Cooper JW; Lei QP
J Am Soc Mass Spectrom; 2019 Dec; 30(12):2576-2579. PubMed ID: 31595432
[TBL] [Abstract][Full Text] [Related]
60. The effect of storage temperatures on the in vitro properties of a polyanhydride implant containing gentamicin.
Tian Y; Li L; Gao X; Deng J; Stephens D; Robinson D; Chang H
Drug Dev Ind Pharm; 2002 Sep; 28(8):897-903. PubMed ID: 12378959
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
